Loading asset research
Cardiol Therapeutics Inc. Class A Common Shares
CRDLNasdaq · USD · StocksQuote as of · Exchange session not verified$2.00
+0.76%
Today
CRDL
Loading 1D prices…
Market cap
$233.1M
Volume
1.2M
52w high
$2.3452w low
$0.88Company profile
Cardiol Therapeutics Inc. Class A Common Shares
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38, a novel subcutaneously administered drug formulation of cannabidiol for the treatment of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.
Sector
Health Care
Industry
Biological Products, (No Diagnostic Substances)
Exchange
Nasdaq
Display currency
USD
Location
Oakville, ON, United States
Employees
18
Fiscal year end
1231
CIK
1702123
Session & valuation
Open$2.03
Previous close$1.98
Day high$2.08
Day low$1.95
30-day avg. volume1.5M
Outstanding shares100.3M
Diluted EPS-$0.39
Latest annual period
P/E (trailing)-5.12
P/E (forward)-8.32
Price / book13.31
Beta0.61
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2836
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| CGENCompugen Ltd. Ordinary Shares | $234M | $72.8M | +48.57% | $0.38 | +0.61% | Buy |
| IVVDInvivyd Inc. Common Stock | $231.5M | $53.4M | -98.25% | -$0.30 | +1.10% | Buy |
| ALECAlector Inc. Common Stock | $238.9M | $21M | -679.50% | -$1.39 | +0.00% | Hold |
| TARAProtara Therapeutics Inc. Common Stock | $225.7M | $0.00 | — | -$1.34 | +1.32% | Buy |
| AVXLAnavex Life Sciences Corp. Common Stock | $242.9M | $0.00 | — | -$0.03 | -1.50% | Buy |